• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Hip implant recall on track to be costliest device issue since Medtronic’s Sprint Fidelis | MassDevice.com On Call

Hip implant recall on track to be costliest device issue since Medtronic’s Sprint Fidelis | MassDevice.com On Call

August 23, 2011 By MassDevice staff

MassDevice On Call

MASSDEVICE ON CALL — Metal-on-metal hip implants complaints have skyrocketed in recent months, numbering more than 5,000 since January, which is more than for the past four years combined.

Hip replacements are one of the most common procedures in the U.S., and one estimate puts the number of patients with metal-on-metal implants at 500,000.

The high-profile recall of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics’s metal-on-metal implant, which recently raised eyebrows over JNJ’s decision to outsource the recall, could cost $1 billion on its own.

The JNJ implant accounted for three-quarters of the FDA complaints, the New York Times reported. Other hip makers include Biomet Inc. and Zimmer Holdings Inc. (NYSE:ZMH), which were targets in a May FDA probe into the devices.*

The growing concern puts metal-on-metal hip replacement devices on track to be the biggest and most expensive medical implant quagmire since Medtronic recalled its Sprint Fidelis lead in 2007, according to the paper.

Click here to read former Medtronic CEO Bill Hawkins’ take on the Sprint Fidelis lead recall in a MassDevice exclusive interview.

Historic 8 millionth U.S. patent goes to med-tech

The 8 millionth patent issued by the Patent and Trademark office goes to Second Sight Medical’s Argus II retinal prosthesis, Medgadget reported.

Stenting for infants and toddlers?

PCI intervention is a safe option for children fifteen months and younger, according to a new study published in the August issue of Catheterization and Cardiovascular Interventions, a journal of The Society for Cardiovascular Angiography and Interventions.

Heart failure treatments are right on time

Angioplasty treatments for heart attack patients are occurring within the recommended 90-minute window from when a patient enters the hospital to when the blocked artery is opened more regularly than five years ago, the Wall Street Journal’s Health Blog reported.

Married heart surgery patients have a higher survival rate

Regardless of whether the marriage is blissful or on the rocks, people who were married at the time of having a coronary bypass surgery were 2.5 times more likely to live another 15 years, although a happy marriage does give you a bit more of a boost, CNN reported.

*Correction, August 24, 2011: This article originally referred to Stryker Corp. as a manufacturer of metal-on-metal hip implants; it is not, and never has been. Return to the corrected sentence.

Filed Under: News Well, Pediatrics, Recalls, Stents Tagged With: Biomet, depuysynthes, Hips, Johnson and Johnson, second-sight-medical, Stryker, Zimmer Biomet

More recent news

  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland
  • Brain Navi wins FDA nod for neurosurgical robot
  • Adona Medical completes enrollment in first-in-human interatrial shunt trial

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy